Intervention

MRI prostate

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting1

Common conditions3

Lead sponsors shown3

Clinical trials

3 shown

EDRN Prostate MRI Biomarker StudyNCT03784924 · 2019-02-04

RECRUITING

European Multicenter Validation of PCaVision: A Head-to-Head Diagnostic Accuracy Study Comparing Multiparametric Transrectal Ultrasound to MRI for Clinically Significant Prostate Cancer DetectionNCT06935487 · 2025-04-01

ACTIVE_NOT_RECRUITING

MRI Prostate for Chinese Men Being Screened for Prostate CancerNCT03891732 · 2019-01-19

ACTIVE_NOT_RECRUITING

Common conditions

Prostate Cancer3 PSA2 MRI1

Leading sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1 Chinese University of Hong Kong 1 University of Michigan 1

Trial status mix

ACTIVE_NOT_RECRUITING2

RECRUITING1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.